Tag: RSV
FDA approves 2024-2025 COVID-19 vaccine; plan now for respiratory virus vaccinations
The U.S. Food and Drug Administration (FDA) today approved the updated 2024-2025 COVID-19 vaccine. The shots could be available in Oregon in the coming weeks. Oregon, like the United States, is experiencing a late summer wave of COVID-19 activity, which follows a similar pattern from previous summers since the pandemic began. And don’t forget – […]
COVID-19 transmission low; flu transmission decreasing in Oregon
The U.S. Food and Drug Administration’s (FDA) advisory committee will discuss recommendations for the next updated formula (2024-2025) of the COVID-19 vaccine June 5. At this point we are still seeing low COVID-19 and low-moderate flu transmission in Oregon. Respiratory syncytial virus (RSV) season ended March 30, when transmission levels in Oregon met the criteria […]
COVID-19 and flu transmission active in Oregon; RSV season has ended
At this point we are still seeing active COVID-19 and flu transmission in Oregon, while transmission of RSV (respiratory syncytial virus) has slowed significantly and Oregon met criteria for the end of RSV season March 30. (Note: Flu and RSV activity typically follows a seasonal pattern—increasing in the fall and winter and dissipating over the […]
COVID-19 transmission in Oregon remains moderate; isolation guidelines reminder
If you test positive for COVID-19, symptom-based isolation guidelines in Oregon are as follows: The symptom-based isolation recommendations have been in place since May 2023, when the federal COVID-19 public health emergency ended, and there is no plan to change them at this time. “Because COVID-19 is exceptionally transmissible and a large proportion of cases […]
COVID-19 spread has increased in Oregon; hospitalizations hold steady
This week we reported a 10.4% test positivity rate for COVID-19, which indicates ongoing high community transmission in Oregon, based on data reported to health officials during the week ending Jan. 6. “The continued high amount of spread of COVID-19 in Oregon is made clear to us in the fact that many of us have […]
CDC recomienda medicamento para proteger a bebés contra el VRS
Bebés y niños de 1 año pronto podrán recibir un nuevo medicamento para estar protegidos contra el virus respiratorio sincitial, (VRS). El panel asesor de los Centros para el Control y Prevención de Enfermedades (CDC, por sus siglas en inglés) votó ayer por unanimidad para recomendar el medicamento de anticuerpos monoclonales nirsevimab (Beyfortus) para usar […]
CDC recommends medication to protect babies against RSV
Available in Spanish Update: Aug. 4, 2023 – This article has been updated to reflect the CDC’s support for its advisory panel’s vote, as stated in this press release. Infants and 1-year-olds will soon be able to receive a new medication to protect them from RSV (respiratory syncytial virus). The Centers for Disease Control and […]
New vaccines for COVID-19 and RSV on the horizon
COVID-19 vaccines Federal health officials are asking Pfizer, Moderna and Novavax to create a new COVID-19 vaccine in time for the fall. Instead of another bivalent shot (which Moderna and Pfizer introduced last year), the U.S. Food and Drug Administration’s (FDA) advisory committee wants all three companies to produce a monovalent vaccine that targets only […]
Why are so many people sick this winter?
Available in Spanish You may have seen it in the news, on your social media feed, in your family group chat or in announcements from your kid’s school: this is a bad season for respiratory viruses. With COVID-19, RSV and influenza circulating, many people have found themselves under the weather. The surge of respiratory viruses, […]